Júlia Martinková

Júlia Martinková

Auto-generated profile, based on publicly available information

Júlia Martinková

Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University in Prague, Motol and Homolka University Hospital

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMartin Schwarz
Martin Schwarz
JGJan Geryk
Jan Geryk
MHMarkéta Havlovicová
Markéta Havlovicová
MMMichaela Mihulová
Michaela Mihulová
MTMarek Turnovec
Marek Turnovec
VMVeronika Moslerová
Veronika Moslerová
Cluster analyzes of facial models of autistic patients aim to clarify whether it is possible to diagnose autism on the basis of facial features and further to stratify the autism spectrum disorder. We performed a cluster analysis of sets of 3D scans of ASD patients (116) and controls (157) using Euclidean and geodesic distances in order to recapitulate the published results on the Czech population. In the presented work, we show that the major factor determining the clustering structure and consequently also the correlation of resulting clusters with autism severity degree is body mass index corrected for age (BMIFA). After removing the BMIFA effect from the data in two independent ways, both the cluster structure and autism severity correlations disappeared. Despite the fact that the influence of body mass index (BMI) on facial dimensions was studied many times, this is the first time to our knowledge when BMI was incorporated into the faces clustering study and it thereby casts doubt on previous results. We also performed correlation analysis which showed that the only correction used in the existing clustering studies—dividing the facial distance by the average value within the face—is not eliminating correlation between facial distances and BMIFA within the facial cohort.

17 June 2025 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
KGKaterina Gregorova
Katerina Gregorova
LPLukas Plachy
Lukas Plachy
PDPetra Dusatkova
Petra Dusatkova
KMKlara Maratova
Klara Maratova
JMJulia Martinkova
Julia Martinkova
SPStepanka Pruhova
Stepanka Pruhova
The purpose of this study is to elucidate the genetic causes and phenotypic presentation of nonfamilial tall stature (nFTS) and to compare these findings with those of familial tall stature (FTS) from the same population that was previously studied. Children with nFTS (defined as a height > + 2 SDs with both parents’ heights < + 2 SDs) underwent endocrine and anthropometric examinations and genetic testing (karyotyping, SHOX gene dosage analysis and next-generation sequencing of 786 growth-associated genes). Exome sequencing was performed in patients with negative genetic results and a height > + 3 SDs. A total of 55 children with nFTS were enrolled. The median height was + 2.8 SD (2.4–3.2 SD), and the median midparental height was + 0.7 SD (0.4–0.9 SD). Genetic causes of tall stature were identified in 6/55 (11%) children. Specifically, four children had gonosomal aneuploidy (47,XXY [2x], 47,XXX, 48,XXXX), one had a heterozygous complex rearrangement including SHOX gene duplication, and one carried a pathogenic variant in the TGFBR2 gene leading to Loeys–Dietz syndrome. A genetic cause of tall stature was significantly less common in nFTS (11%) than in our previously published cohort with FTS (32%). Conclusion: Cytogenetic abnormalities were the predominant genetic alteration identified in children with nFTS, confirming the justification of karyotype analysis in this cohort. The probability of genetic alterations was greater in children with FTS than in those with nFTS. Our findings suggest that the current guidelines for complex investigation are efficient for children with nFTS but need revision in children with FTS. What is known – what is new• Although tall stature is generally considered beneficial, it can be associated with health risks which need to be recognized in time. Tall stature without intellectual impairment is usually considered to be polygenic.• However, the cause of familial tall stature was monogenic more often than it was thought previously.• Children with non-familial and apparently non-syndromic tall stature have never been systematically investigated.• Monogenic causes of non-familial tall stature were observed in 11% of patients, including a participant with Loeys–Dietz syndrome.

7 October 2026 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
JMJúlia Martinková
Júlia Martinková
HŘHana Řezáčová
Hana Řezáčová
AŠAlena Šantavá
Alena Šantavá
JDJana Drábová
Jana Drábová
MŠMiroslav Štolfa
Miroslav Štolfa
AKAnna KřEpelová
Anna KřEpelová
46,XX testicular disorder of sex development (DSD), also known as XX male syndrome, is a rare condition where an individual with a 46,XX karyotype develops a male phenotype. In 90% of cases, the syndrome results from the translocation of the SRY gene to the X chromosome or an autosome. The remaining 10% of individuals lack the SRY gene. We report a case of an SRY- negative 3-year-old boy with a 46,XX karyotype exhibiting normal male external genitalia. Array CGH analysis revealed a 723-kb duplication of the Xq27.1q27.2 region, encompassing the SOX3 gene. The duplication was tandem. An imbalance in X chromosome methylation was observed, with a ratio of 4.5:1. The patient’s mother and grandmother, both with a 46,XX karyotype, were asymptomatic carriers of this duplication. To date, SOX3 duplication has been documented in 12 SRY- negative male patients and one female patient; eleven of these individuals exhibited various disorders of genital development. In contrast, only two previously reported patients displayed normal male genitalia, although associated with infertility. This case, the first reported in the Czech Republic, further supports the hypothesis that SOX3 overexpression during gonadal development, accompanied by imbalanced X-chromosome inactivation, may induce testis formation, thereby compensating for the absence of the SRY gene in SRY -negative 46,XX male patients.

18 September 2026 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
JMJúlia Martinková
Júlia Martinková
MMMichaela Mihulová
Michaela Mihulová
MBMiroslava Balaščaková
Miroslava Balaščaková
JTJan Trachta
Jan Trachta
AKAnna KřEpelová
Anna KřEpelová
Background: Steroidogenic factor 1 (SF-1), encoded by the NR5A1 gene, is a critical transcriptional regulator of adrenal and gonadal development. Pathogenic NR5A1 variants lead to a broad phenotypic spectrum characterized by insufficient virilization, including gonadal and testicular dysgenesis, ambiguous genitalia, hypospadias, micropenis, cryptorchidism, anorchia, and male infertility. This case report characterizes the clinical and genetic findings in a boy and his father with differences of sex development (DSD) caused by a heterozygous NR5A1 frameshift variant, thereby expanding our understanding of phenotypic mechanisms, paternal inheritance, and reproductive potential in this disorder. Case presentation: We report a unique case of a Czech family in which a father and his son exhibited a 46,XY karyotype, genital malformations, and palpable testes. Exome sequencing identified the heterozygous frameshift variant, c.614dup p.(Gln206Thrfs*20), in the NR5A1 gene in both individuals. This rare NR5A1 variant had previously been reported only in 46,XY female patients with DSD. Conclusion: Here, we present the first report of paternal transmission of the pathogenic NM_004959.5(NR5A1):c.614dup p.(Gln206Thrfs*20) variant to an affected son. Despite the associated genital malformation and the genetic variant, the father achieved successful reproduction via in vitro fertilization.

4 June 2026 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
JMJúlia Martinková
Júlia Martinková
EVEmílie Vyhnálková
Emílie Vyhnálková
MSMartin Schwarz
Martin Schwarz
MBMiroslava Balaščaková
Miroslava Balaščaková
VFVeronika Fáberová
Veronika Fáberová
AKAnna KřEpelová
Anna KřEpelová
Background: Smith‐Lemli‐Opitz syndrome (SLOS) is a common autosomal recessive disorder caused by pathogenic variants in the DHCR7 gene, resulting in a deficiency of the enzyme 7‐dehydrocholesterol reductase. Two forms of SLOS are recognized based on the severity of associated symptoms. Type I is characterized by a milder phenotype, whereas type II is more severe and frequently results in fetal loss or early neonatal death. We observed two unrelated patients: a 5‐year‐old boy and a 3.5‐year‐old girl, with elevated 7‐DHC levels, a milder phenotype, and an identical genotype. Methods: Variants were confirmed by Sanger sequencing. Results: A rare heterozygous likely pathogenic variant, c.89G>C p.(Gly30Ala), and a pathogenic variant, c.964‐1G>C, in the trans position in the DHCR7 gene were identified in both patients. Conclusion: The two unique patients presented here suggest that the c.89G>C p.(Gly30Ala) variant is associated with a mild SLOS phenotype, which may be overlooked and unrecognized in clinical practice. Information about this rare DHCR7 variant is important for diagnostic awareness of SLOS, especially within the Central European population. We present clinical data and a literature review of the DHCR7 variants associated with the mild SLOS phenotype.

13 August 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMichaela Mihulová
Michaela Mihulová
VMVeronika Moslerová
Veronika Moslerová
MSMartin Schwarz
Martin Schwarz
JMJúlia Martinková
Júlia Martinková
KKKarolina Kočandrlová
Karolina Kočandrlová
DTDana Thomasová
Dana Thomasová
Verification and visualization of the possible impact of PKD1 causative variants associated with autosomal dominant polycystic kidney disease (ADPKD) on facial phenotype using three-dimensional (3D) geometric morphometry. Three-dimensional facial scans of 39 adult patients with ADPKD were obtained, together with 3D scans of 39 sex and age matched healthy individuals. The 3D facial scans were processed, and morphometric analyses were performed using geometric morphometry to quantified potential phenotypical traits in ADPKD patients. In ADPKD patients, we observed several statistically significant differences in facial morphology compared with healthy controls. In both sexes, considerable retrusion of the supraorbital arches and, conversely, prominence of the suborbital region were detected. In males, additional retrusion along the entire midline was observed, with significant changes at the nasal tip and chin. In females, the midline showed a tendency toward prominence, although these differences were not significant compared with controls. Asymmetry analysis revealed that males with ADPKD exhibit less pronounced asymmetry, with an asymmetry pattern very similar to that of controls. In contrast, females with ADPKD differ from controls in the midface and lower face, showing laterally reversed asymmetry deviations. Patients in the truncating variant group and non-truncating variant groups showed distinct phenotypic patterns in the forehead, philtrum, and chin areas. Our findings suggest the presence of distinct facial phenotypic traits in ADPKD patients carrying pathogenic PKD1 variants compared with healthy controls. In addition, we observed partial subgroup-specific differences according to sex and mutation type.